Global EditionASIA 中文双语Français
China
Home / China / Latest

China conditionally approves four self-developed COVID-19 vaccines: official

Xinhua | Updated: 2021-02-26 20:09
Share
Share - WeChat
A staff member checks the packages of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd, in Beijing, Dec 25, 2020. [Photo/Xinhua]

BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.

China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.

China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US